PsyIndex Weekly Update – May 31, 2021 – June 4, 2021
May 31, 2021 – June 4, 2021
The PsyIndex moved marginally higher last week as new companies continue to announce plans to go public. With the recent launch of the first U.S. ETF, investors also have much easier access to the market.
Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. Press Release
BetterLife Pharma Inc. (CSE: BETR) appointed Henri Sant-Cassia of The Conscious Fund to its Board of Directors. Press Release
Optimi Health Corp. (CSE: OPTI) announced DTC eligibility and an uplisting to the OTCQB. Press Release
Silo Wellness Inc. (CSE: SILO) partnered to establish the first legal brick and mortar psychedelic and functional mushroom shop in the Western hemisphere. Press Release
The Good Shroom Co. (TSXV: MUSH) signed a contract with a top-tier Canadian retail distributor, Ecotrend. Press Release
Delic Holdings acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures Ltd., a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development.
Industry Developments
PharmaTher and TSRL have teamed up to develop microneedle patches to deliver psychedelics and antivirals. via Fierce Pharma
Nearly 40 percent of Americans approve the use of psychedelics for medical purposes. via KABC
The first psychedelics ETF comes to the U.S. as bills move forward in key states. via Benzinga